The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...
Shares of Medtronic PLC MDT slipped 5.70% to $82.88 Friday, on what proved to be an all-around grim trading session for the ...
Today's Research Daily features new research reports on 12 major stocks, including Mastercard Incorporated (MA), Medtronic ...
Medtronic (NYSE: MDT) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by ...
Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...
Adam Savage of "MythBusters" sat down with Fox News Digital to explore the science of healthy and longer lives after forming ...
Explore more
Bearish flow noted in Medtronic (MDT) with 25,355 puts trading, or 7x expected. Most active are Jun-25 100 calls and Jan-26 85 puts, with total ...
A U.S. appeals court has vacated a decision from the U.S. Patent and Trademark Office, reviving a spat between Recor Medical ...
2d
Zacks.com on MSNMedtronic (MDT) Advances But Underperforms Market: Key FactsMedtronic (MDT) closed at $88.86 in the latest trading session, marking a +0.42% move from the prior day. This change lagged the S&P 500's 0.67% gain on the day. Meanwhile, the Dow experienced a rise ...
Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...
4d
Medical Device Network on MSNMedtronic reports late-breaking data from TAVR system trial for aortic stenosisMedtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results